CONSOLIDATED STATEMENTS OF OPERATIONS - USD ($) shares in Millions, $ in Millions	3 Months Ended		9 Months Ended
	Sep. 30, 2021	Sep. 30, 2020	Sep. 30, 2021	Sep. 30, 2020
Income Statement [Abstract]
Net sales	$ 1,069	$ 895	$ 3,163	$ 2,260
Cost of products sold	478	453	1,395	1,174
Gross profit	591	442	1,768	1,086
Selling, general, and administrative expenses	394	315	1,177	935
Research and development expenses	35	27	112	79
Goodwill impairment	0	0	0	157
Provisions	3	18	11	62
Operating income (loss)	159	82	468	(147)
Other income and expenses:
Interest expense, net	13	14	43	32
Other expense (income), net	8	1	4	4
Income (loss) before income taxes	138	67	421	(183)
Provision (benefit) for income taxes	35	13	102	(1)
Net income (loss)	103	54	319	(182)
Less: Net income attributable to noncontrolling interest	0	1	0	0
Net income (loss) attributable to Dentsply Sirona	$ 103	$ 53	$ 319	$ (182)
Net income (loss) per common share attributable to Dentsply Sirona:
Basic (in dollars per share)	$ 0.47	$ 0.25	$ 1.46	$ (0.83)
Diluted (in dollars per share)	$ 0.47	$ 0.25	$ 1.45	$ (0.83)
Weighted average common shares outstanding:
Basic (in shares)	218.6	218.5	218.6	219.4
Diluted (in shares)	220.5	219.2	220.7	219.4